Amandine Lejeune

Associate Professor of Clinical Medical Oncology

University of California

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Amandine Lejeune is an Associate Professor of Clinical Medical Oncology at the University of California. Her research focuses on the safety and efficacy of various treatments in veterinary oncology, including chemotherapy and radiotherapy protocols, particularly in dogs and cats. Recent publications explore topics such as the pharmacokinetics of doxorubicin, the treatment of mesenchymal neoplasia, and molecular diagnostic techniques in canine histiocytic sarcoma.

Articles (11)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

View details

Patricia A. Pesavento

University of California

UNITED STATES

View details

Katherine Sarah Hansen

UNITED STATES

View details

Jenna Burton

Associate Professor, Medical Oncology

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amandine Lejeune

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Safety, Efficacy and Doxorubicin Pharmacokinetics During Cannabidiol/Cannabidiolic Acid Rich Hemp Oil Use in Dogs With Lymphoma Undergoing CHOP Chemotherapy

Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs

Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases

Characterization of expression and prognostic implications of transforming growth factor beta, programmed death-ligand 1, and T regulatory cells in canine histiocytic sarcoma.

Longevity and mortality in cats: A single institution necropsy study of 3108 cases (1989-2019).

Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response.

RNA in situ hybridisation as a molecular diagnostic technique targeting IBA-1 and CD204 in canine histiocytic sarcoma.

Comparison of the clinical, ultrasound, and CT findings in 13 dogs with gastric neoplasia.

Evaluation of ponatinib in vitro effect in three canine mast cell tumor cell lines expressing FGFR-1, PDGFR-α, and VEGFR-2.

Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.

Analysis of canine myeloid-derived suppressor cells (MDSCs) utilizing fluorescence-activated cell sorting, RNA protection mediums to yield quality RNA for single-cell RNA sequencing.

Collaborators (9)

Rachel Brady

Sandra Axiak-Bechtel

Michael Dark

Michael Kent

Robert Rebhun

Luke Wittenburg

Patricia A. Pesavento

Katherine Sarah Hansen

Jenna Burton

Make your next move.